Skip to main content

Table 2 Summary of agreement scoresa

From: Hypertensive disorders of pregnancy (HDP) management pathways: results of a Delphi survey to contextualise international recommendations for Indonesian primary care settings

Recommendations Agreement score (%) Quartile 1 (25th percentile) Median Quartile 3 (75th percentile) Interquartile ranges (IQR) Standard Deviation (±)
First-round
Mean agreement scores on
 Definitions 86.6 4.0 4.0 4.7 0.7 0.8
 Risk factors 81.9 3.8 4.0 4.6 0.8 0.8
 Screening and diagnosis 81.9 3.7 4.1 4.7 1.0 0.8
 Prevention 81.1 3.8 4.0 4.4 0.6 0.8
 Long-term follow up in primary care 82.5 3.6 3.9 4.7 1.1 0.7
Second-round
Mean agreement scores on:
 Management 83.0 3.8 4.1 4.9 1.1 0.8
 Monitoring 84.1 3.7 4.0 4.6 0.9 0.7
 Facilities 96.9 4.0 5.0 5.0 1.0 0.5
 Surveillance 98.0 4.0 4.5 5.0 1.0 0.5
First-round statements that achieved consensus in the second-round
 High-risk preeclampsia: previous history of systemic lupus erythematosus. 72.9 3.0 4.0 4.3 1.3 0.9
 This test is recommended as a baseline reference for women with a high risk of preeclampsia: creatinine 70.8 3.0 4.0 5.0 2.0 1.0
 A GP can prescribe low dose aspirin as prophylaxis for preeclampsia. 70.8 3.0 4.0 4.0 1.0 0.9
 Aspirin 75-150 mg is given daily at bedtime 70.8 3.0 4.0 4.0 1.0 0.8
Third-round
Mean agreement scores on:
 Hypertensive disorders of pregnancy (HDP) diagnosis flowchart. 86.5 4.0 4.0 4.0 0.0 0.8
  HDP management pathways in primary care 83.8 4.0 4.0 5.0 1.0 1.0
 Surveillance pathway for women with HDP in primary care. 86.5 4.0 4.0 5.0 1.0 0.8
First-round statement that achieved consensus in the third-round
 This test is recommended as a baseline reference for women with high risk of preeclampsia: platelet count 70.8 3.0 4.0 4.0 1.0 1.0
  1. aFive-point Likert scale used in the study: 1 = strong disagreement, 2 = disagreement, 3 = indicated neutral position, 4 = agreement, and 5 = strong agreement